Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.6K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.6K
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

22
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
22
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

477
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
477
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

167
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
167
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

279
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
279
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

475
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
475

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lingering Effects Of The COVID-19 Pandemic On Non-COVID-19 Death Rates In The US, 2020-24.

Health affairs (Project Hope)·2026
Same author

Mental health and mortality trends in the United States.

Journal of health economics·2025
Same author

US State Restrictions and Excess COVID-19 Pandemic Deaths.

JAMA health forum·2024
Same author

Estimating Drug Involvement in Fatal Overdoses With Incomplete Information.

American journal of preventive medicine·2023
Same author

The Evolution of Excess Deaths in the United States During the First 2 Years of the COVID-19 Pandemic.

American journal of epidemiology·2023
Same author

Marijuana legalization and opioid deaths.

Journal of health economics·2023

Related Experiment Video

Updated: Feb 15, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

7.0K

Drug involvement in fatal overdoses.

Christopher J Ruhm1,2

  • 1Frank Batten School of Leadership and Public Policy, University of Virginia, USA, P.O. Box 400893, Charlottesville, VA 22904-4893, United States.

SSM - Population Health
|January 20, 2018
PubMed
Summary

Fatal drug overdoses increased significantly between 1999 and 2014. While opioid analgesics were initially prominent, heroin and combination drug use became increasingly significant drivers of these drug-related deaths.

Keywords:
Drug cocktailsDrug deathsDrug fatalitiesDrug mortalityDrug poisoning deathsFatal overdosesOverdose deaths

More Related Videos

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.9K
Using Eye Movements to Evaluate the Cognitive Processes Involved in Text Comprehension
06:49

Using Eye Movements to Evaluate the Cognitive Processes Involved in Text Comprehension

Published on: January 10, 2014

28.2K

Related Experiment Videos

Last Updated: Feb 15, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

7.0K
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.9K
Using Eye Movements to Evaluate the Cognitive Processes Involved in Text Comprehension
06:49

Using Eye Movements to Evaluate the Cognitive Processes Involved in Text Comprehension

Published on: January 10, 2014

28.2K

Area of Science:

  • Public Health
  • Epidemiology
  • Toxicology

Background:

  • Drug overdose deaths have risen dramatically in recent decades.
  • Accurate data on drug involvement is crucial for understanding trends.
  • Death certificates often lack specificity regarding involved substances.

Purpose of the Study:

  • To identify drug categories most associated with increased fatal overdoses from 1999-2014.
  • To analyze trends considering both any and exclusive drug involvement.
  • To account for uncertainties in reported drug involvement on death certificates.

Main Methods:

  • Analysis of Multiple Cause of Death (MCOD) files.
  • Application of statistical adjustment methods for underreported drug involvement.
  • Distinction between any versus exclusive drug involvement.

Main Results:

  • Opioid analgesics were a major factor in overdose increases for analyses starting in 1999.
  • Heroin and other drugs became more significant in more recent time periods.
  • Combination drug use was consistently important across all analyzed periods.

Conclusions:

  • Drug overdose trends are dynamic, with shifts in primary contributing substances over time.
  • Combination drug use presents unique challenges for data interpretation and policy development.
  • Accurate reporting and statistical adjustments are vital for effective public health interventions against fatal overdoses.